# Study of Aspirin in Patients With Vestibular Schwannoma

> **NCT03079999** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 97 (actual)

## Conditions studied

- Vestibular Schwannoma
- Acoustic Neuroma
- Neurofibromatosis 2

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03079999
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-11
- **Primary completion:** 2026-08
- **Final completion:** 2029-02
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079999, "Study of Aspirin in Patients With Vestibular Schwannoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03079999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*